Scarica l'app Stockscreener
6.68
2.45%
0.16
Nuvectis Pharma Inc Azioni (NVCT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Research and Development |
1.82%
3.613
|
3.68 | 4.496 | 2.819 | 2.943 |
| Operating Income/Loss |
18.44%
-6.595
|
-5.568 | -6.449 | -4.359 | -4.643 |
| Income/Loss From Continuing Operations Before Tax |
18.79%
-6.334
|
-5.332 | -6.248 | -4.153 | -4.428 |
| Income/Loss From Continuing Operations After Tax |
18.79%
-6.334
|
-5.332 | -6.248 | -4.153 | -4.428 |
Net Income/Loss
|
18.79%
-6.334
|
-5.332 | -6.248 | -4.153 | -4.428 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7.17%
21.37
|
19.94 | 0.2151 | 17.23 | 16.90 |
| Diluted Average Shares |
7.17%
21.37
|
19.94 | 0.2151 | 17.23 | 16.90 |
| Basic Earnings Per Share |
11.11%
-0.30
|
-0.27 | -0.36 | -0.24 | -0.26 |
| Diluted Earnings Per Share |
11.11%
-0.30
|
-0.27 | -0.36 | -0.24 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):